The german Healthcare market                                                 Florence, 14th March 2012© Camera di Commerci...
The german Healthcare market                 Biomedical market                 Pharmaceutical market                 Bi...
The german Healthcare market                                                 There are 14 main german                    ...
The german Healthcare market                                           The german biomedical MarketEurope’s leading busin...
The german Healthcare market                                   The german biotechnological market German biotechnology ha...
The german Healthcare market                                                  Pharmaceutical - Market ≈300 companies Wor...
Clusters© Camera di Commercio Italiana per la Germania
Clusters© Camera di Commercio Italiana per la Germania
Clusters© Camera di Commercio Italiana per la Germania
Clusters© Camera di Commercio Italiana per la Germania
Conclusions Companies will continue to look to innovation to drive their strategy and future  success. Companies that ca...
Upcoming SlideShare
Loading in...5
×

The german Healthcare market

1,754
-1

Published on

Published in: Business, Economy & Finance
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,754
On Slideshare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

The german Healthcare market

  1. 1. The german Healthcare market Florence, 14th March 2012© Camera di Commercio Italiana per la Germania
  2. 2. The german Healthcare market Biomedical market Pharmaceutical market Biotechnological market© Camera di Commercio Italiana per la Germania
  3. 3. The german Healthcare market There are 14 main german “bioregions” which provide a platform for industrial development, facilitating the organic interaction of corporate and institutional resources in the 16 German Federal States and abroad© Camera di Commercio Italiana per la Germania
  4. 4. The german Healthcare market The german biomedical MarketEurope’s leading business location for medical technology and 3rd biggest medicaltechnology producer and medical services provider in the world -> medium-sized enterprisesector, strong exporters, and market leaders200 billion € per year -> increasing all the timeEurope’s strongest location for innovation in this industryTotal turnover of this sector ≈ 18.3 billion €87,000 employees7% growth rate per year © Camera di Commercio Italiana per la Germania
  5. 5. The german Healthcare market The german biotechnological market German biotechnology has actually grown during the crisis. Number of employees exceeded the 30,000 mark – Number of employees in dedicated biotechnology companies =>14950 – Number of employees in the other biotechnology-active companies =>16650 R&D expenditure of dedicated biotech. Companies =>1.05 billion € Number of dedicated biotechnology companies =>531 Number of the other biotechnology-active companies (e. g. pharma, chemicals or seeds manufacturers) => 114 In terms of turnover, total revenues stood at 2 billion € ≈1 billion € research spending per year © Camera di Commercio Italiana per la Germania
  6. 6. The german Healthcare market Pharmaceutical - Market ≈300 companies Workforce of 126,000 people Total turnover of 41.5 billion € In sales terms, world’s third largest pharmaceutical market ->Net sales are about 22.5 billion € per year Drugs production with a market value of ≈27.1 billion € per year Europe’s largest biopharmaceuticals producer Biopharmaceutical sales account for 16% of the whole German pharmaceutical market. Since 2000, this level has doubled (10 years) Share of the global market remains at around 5% percent Around 5 billion € are invested in R&D per year Export ratio of around 56% © Camera di Commercio Italiana per la Germania
  7. 7. Clusters© Camera di Commercio Italiana per la Germania
  8. 8. Clusters© Camera di Commercio Italiana per la Germania
  9. 9. Clusters© Camera di Commercio Italiana per la Germania
  10. 10. Clusters© Camera di Commercio Italiana per la Germania
  11. 11. Conclusions Companies will continue to look to innovation to drive their strategy and future success. Companies that can sustain their focus on innovation will be the eventual “winners” in the marketplace. The growing complexity of biotechnological research means that it is frequently necessary to pool expertise from different research disciplines in different countries Only with innovative new technologies and products, driven by robust research and development inland and in cooperation with partners abroad, can a full growth be achieved and sustained. -> let European countries cooperate with each other! © Camera di Commercio Italiana per la Germania

×